REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dali Pharmaceutical Co., Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dali Pharmaceutical Co., Ltd Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Dali Pharmaceutical Co., Ltd. produces and sells Chinese and Western medicines. The company's core products are Xingnaojing injection and Shenmai injection. It was founded in 1996 and is headquartered in Dali City, China.

Headquarters
No. 118, Huancheng West Road, Xiaguan, Dali City, Yunnan Province
Dali; Yunnan; Postal Code: 671000

Contact Details: Purchase the Dali Pharmaceutical Co., Ltd report to view the information.

Website: http://www.daliyaoye.cn

Basic Information
Total Employees:
Purchase the Dali Pharmaceutical Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Dali Pharmaceutical Co., Ltd report to view the information.
Registered Capital:
Purchase the Dali Pharmaceutical Co., Ltd report to view the information.
Financial Auditors:
Purchase the Dali Pharmaceutical Co., Ltd report to view the information.
Incorporation Date:
October 21, 1996
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
23.31%
Purchase this report to view the information.
18.7%
Purchase this report to view the information.
13.5%
Purchase this report to view the information.
11.94%
Purchase this report to view the information.
3.06%
Subsidiaries
Dali Pharmaceutical Sales Co., Ltd.
100%
Dali Ruijin Property Management Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Dali Pharmaceutical Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-53.99%▼
Total operating revenue
-52.93%▼
Operating profit (EBIT)
-37.77%▼
Net Profit (Loss) for the Period
-12.72%▼
Total assets
-0.87%▼
Total equity
-5.48%▼
Operating Profit Margin (ROS)
-28.87%▼
Net Profit Margin
-26.24%▼
Return on Equity (ROE)
-0.53%▼
Debt to Equity Ratio
-1.89%▼
Quick Ratio
-1.82%▼
Cash Ratio
-0.11%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Kunming Longjin Pharmaceutical Co., Ltd.
 
Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港))
Broncus Holding Corporation (Hong Kong) (Broncus Holding Corporation (香港))
 
Jacobio Pharmaceuticals Group Company Limited
Beijing Northland Biotech Co.,Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo